Can B (CANB) Asset Impairment Charge : $4.51 Mil (TTM As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Can B Asset Impairment Charge?

Can B's Asset Impairment Charge for the three months ended in Sep. 2024 was $2.55 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 was $4.51 Mil.

Can B Asset Impairment Charge Historical Data

The historical data trend for Can B's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Can B Asset Impairment Charge Chart

Can B Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

0.25

1.21

0.06

1.00

1.83

Can B Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Asset Impairment Charge	Get a 7-Day Free Trial															-0.02	1.80	0.09	0.07	2.55

Can B Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.51 Mil.

Can B Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Can B's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Can B Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Can B Corp (OTCPK:CANB) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

960 South Broadway, Suite 120, Hicksville, NY, USA, 11801

Website

https://www.canbiola.com

Can B Corp is engaged in the business of promoting health and wellness through its development, manufacture and sale of products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. The company focuses on developing a line of proprietary products in the Hemp Industry.

Executives

Mckenzie Webster Ltd	10 percent owner	DMS HOUSE, DR. ROYCE DRIVE, GEORGE TOWN, GRAND CAYMAN E9 KY1-1102
Stanley L Teeple	director, officer: CFO, Director, and Secretary	94 ARTHUR HILL COURT, HENDERSON NV 89014
Andrew Holtmeyer	officer: EVP Business Development	65 LAUREN AVE, SUITE 301, HUNTINGTON STATION NY 11746
Heggenhougen Rolv	director	90 NORTH CHURCH STREET, GEORGETOWN E9 KY1-1102
David J Posel	officer: COO	6103 CARMEL LN SE, LACEY WA 98503
Rolv Heggenhougen	10 percent owner	445 NE 12TH AVENUE, FORT LAUDERDALE FL 33301
Marco Alfonsi	director, 10 percent owner, officer: CEO, Board Member	44 EAST END AVENUE, HICKSVILLE NY 11801
Carl Dilley	director	15500 ROOSEVELT BLVD., SUITE 301, CLEARWATER FL 33760